BOLT BIOTHERAPEUTICS INC (BOLT) Stock Income Statement
NASDAQ:BOLT - Nasdaq - US0977021049 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.64M | 7.69M | 7.88M | 5.73M | 1.26M | |||
| Operating Expenses | 66.90M | 75.93M | 84.07M | 96.05M | 94.05M | |||
| Research and Development | 50.45M | 57.47M | 61.54M | 73.12M | 75.66M | |||
| Selling, General, and Administrative Expenses | 16.45M | 18.46M | 22.53M | 22.93M | 18.39M | |||
| Operating Income | -63.26M | -68.24M | -76.20M | -90.32M | -92.79M | |||
| Interest Income/Expense | 4.70M | 5.25M | 7.00M | 2.22M | 280.00K | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | -6.08M | |||
| Non Recurring Items | -4.79M | -137.00K | N/A | N/A | N/A | |||
| Income Before Taxes | -63.35M | -63.12M | -69.20M | -88.10M | -98.59M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -63.35M | -63.12M | -69.20M | -88.10M | -98.59M | |||
| EBITDA | -61.54M | -66.45M | -74.34M | -88.65M | -91.60M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -33.11 | -33.05 | -36.60 | -47.16 | -52.72 | |||
| Non GAAP EPS | -30.60 | -30.40 | -36.60 | -47.20 | -62.80 | |||
| Statistics | ||||||||
| Profit Margin | -1741.26% | -820.78% | -878.58% | -1537.52% | -7824.60% | |||
| Operating Profit Margin | -1738.84% | -887.33% | -967.45% | -1576.27% | -7364.29% | |||
All data in USD